Effects of Vitamin D in Parkinson's Disease (PD)

• Status: Completed
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: All

Summary

A trial to measure the effects of vitamin D (versus a placebo) on balance, gait, falls, strength, and cognition in persons with Parkinson's disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: VA Office of Research and Development
• Collaborator: Oregon Health and Science University
• Treatments: Calcium; Calcium, Dietary; Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Parkinson's disease;

• ability to ambulate 50 feet;

• ability to cooperate with balance testing;

• vitamin D level less than 40ng/ml;

• balance problems;

• ability to walk 50 feet without the help of another person

Exclusion Criteria:

• MMSE < 25;

• another neurological or orthopedic deficit that in the examiner's opinion would affect testing;

• history of renal stones or hypercalcemia;

• unwillingness to not be on other vitamin D supplementation during the study